Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
627
-
Total 13F shares, excl. options
-
69,130,558
-
Shares change
-
+509,866
-
Total reported value, excl. options
-
$16,274,465,898
-
Value change
-
+$84,036,083
-
Put/Call ratio
-
129%
-
Number of buys
-
298
-
Number of sells
-
299
-
Price
-
$235.35
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2022
As of 31 Dec 2022 WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) had 627 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 69,130,558 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Bank of New York Mellon Corp, STATE STREET CORP, APG Asset Management N.V., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, T. Rowe Price Investment Management, Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 627 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.